These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 2653929)

  • 21. Partial recovery of insulin secretion and action after combined insulin-sulfonylurea treatment in type 2 (non-insulin-dependent) diabetic patients with secondary failure to oral agents.
    Del Prato S; Vigili de Kreutzenberg S; Riccio A; Maifreni L; Duner E; Lisato G; Iavicoli M; Tiengo A
    Diabetologia; 1990 Nov; 33(11):688-95. PubMed ID: 2127573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and pharmacodynamics of insulin glargine given in the evening as compared with in the morning in type 2 diabetes.
    Porcellati F; Lucidi P; Cioli P; Candeloro P; Marinelli Andreoli A; Marzotti S; Ambrogi M; Bolli GB; Fanelli CG
    Diabetes Care; 2015 Mar; 38(3):503-12. PubMed ID: 25524950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overnight normalization of glucose concentrations improves hepatic but not extrahepatic insulin action in subjects with type 2 diabetes mellitus.
    Wise SD; Nielsen MF; Cryer PE; Rizza RA
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2461-9. PubMed ID: 9661629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of metformin action in non-insulin-dependent diabetes.
    Jackson RA; Hawa MI; Jaspan JB; Sim BM; Disilvio L; Featherbe D; Kurtz AB
    Diabetes; 1987 May; 36(5):632-40. PubMed ID: 3552795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM.
    Reaven GM; Hollenbeck C; Jeng CY; Wu MS; Chen YD
    Diabetes; 1988 Aug; 37(8):1020-4. PubMed ID: 3292322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans.
    Fanelli C; Calderone S; Epifano L; De Vincenzo A; Modarelli F; Pampanelli S; Perriello G; De Feo P; Brunetti P; Gerich JE
    J Clin Invest; 1993 Oct; 92(4):1617-22. PubMed ID: 8408616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of recombinant human insulin-like growth factor I and insulin on counterregulation during acute plasma glucose decrements in normal and type 2 (non-insulin-dependent) diabetic subjects.
    Laager R; Keller U
    Diabetologia; 1993 Oct; 36(10):966-71. PubMed ID: 8243878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatic glucose production during intraperitoneal and intravenous closed-loop insulin regulation of blood glucose in type 1 (insulin-dependent) diabetic patients.
    Robert JJ; Chauvet D; Darmaun D; Leblanc H
    Diabetologia; 1993 Nov; 36(11):1185-90. PubMed ID: 8270134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin, glucagon, and catecholamines in prevention of hypoglycemia during fasting.
    Boyle PJ; Shah SD; Cryer PE
    Am J Physiol; 1989 May; 256(5 Pt 1):E651-61. PubMed ID: 2655471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exogenous insulin replacement in type 2 diabetes reverses excessive hepatic glucose release, but not excessive renal glucose release and impaired free fatty acid clearance.
    Woerle HJ; Popa E; Dostou J; Welle S; Gerich J; Meyer C
    Metabolism; 2002 Nov; 51(11):1494-500. PubMed ID: 12404204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of glucose turnover during exercise in pancreatectomized, totally insulin-deficient dogs. Effects of beta-adrenergic blockade.
    Bjorkman O; Miles P; Wasserman D; Lickley L; Vranic M
    J Clin Invest; 1988 Jun; 81(6):1759-67. PubMed ID: 3290252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of hepatic insulin action in obese type 2 diabetic patients.
    Staehr P; Hother-Nielsen O; Levin K; Holst JJ; Beck-Nielsen H
    Diabetes; 2001 Jun; 50(6):1363-70. PubMed ID: 11375337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased epinephrine and skeletal muscle responses to hypoglycemia in non-insulin-dependent diabetes mellitus.
    Shamoon H; Friedman S; Canton C; Zacharowicz L; Hu M; Rossetti L
    J Clin Invest; 1994 Jun; 93(6):2562-71. PubMed ID: 8200993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
    Basu R; Shah P; Basu A; Norby B; Dicke B; Chandramouli V; Cohen O; Landau BR; Rizza RA
    Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physiological importance of deficiency in early prandial insulin secretion in non-insulin-dependent diabetes.
    Bruce DG; Chisholm DJ; Storlien LH; Kraegen EW
    Diabetes; 1988 Jun; 37(6):736-44. PubMed ID: 3289994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The metabolic effect of dodecanedioic acid infusion in non-insulin-dependent diabetic patients.
    Greco AV; Mingrone G; Capristo E; Benedetti G; De Gaetano A; Gasbarrini G
    Nutrition; 1998 Apr; 14(4):351-7. PubMed ID: 9591306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of fatty acids on glucose production and utilization in man.
    Ferrannini E; Barrett EJ; Bevilacqua S; DeFronzo RA
    J Clin Invest; 1983 Nov; 72(5):1737-47. PubMed ID: 6138367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of glyburide on glycemic control, insulin requirement, and glucose metabolism in insulin-treated diabetic patients.
    Simonson DC; Delprato S; Castellino P; Groop L; DeFronzo RA
    Diabetes; 1987 Feb; 36(2):136-46. PubMed ID: 3100365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors.
    Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P
    Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics.
    Baron AD; Schaeffer L; Shragg P; Kolterman OG
    Diabetes; 1987 Mar; 36(3):274-83. PubMed ID: 2879757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.